Retraction

CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis

Citations (6)

6
Total Citations
3
Post-Retraction
(50.0%)
1
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
3 Within 1 year
0 After 2+ years
281 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
FABP4 and S100A12, a notable link between inflammatory mediators and cardiovascular risk in rheumatoid arthritis
Fatemeh khoobbakht, Seyed Askar Roghani, Parviz Soufivand et al. (7 authors)
Research Square (Research Square) Open Access
Published: Apr 2024
281 days after retraction
Global trends and hotspots in Cyclin-dependent Kinase Subunit 2 research from 1999 to 2022: A bibliometric and visualized analysis
Z S Li, Yuanzhen Chen, Bo Zhang et al. (5 authors)
Medicine Open Access
Published: Dec 2023
135 days after retraction
Bioinformatics and next generation data analysis reveals the potential role of inflammation in sepsis and its associated complications
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Aug 2023
17 days after retraction
Retracted: CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis
Disease Markers
Disease Markers Open Access
Published: Jul 2023
Same day as retraction
S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs
Leszek Roszkowski, Bożena Jaszczyk, Magdalena Plebańczyk et al. (4 authors)
International Journal of Molecular Sciences Open Access
Published: Dec 2022
11 citations
200 days before retraction
Quick Stats
Total Citations: 9
Years Since Retraction: 2.3 years
Open Access: Yes
Last Checked: Jul 24, 2025